BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12150707)

  • 1. Novel treatments for recurrent respiratory papillomatosis.
    Armbruster C
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1139-48. PubMed ID: 12150707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis.
    Bergler WF; Götte K
    Eur Arch Otorhinolaryngol; 2000; 257(5):263-9. PubMed ID: 10923940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results.
    Shikowitz MJ; Abramson AL; Freeman K; Steinberg BM; Nouri M
    Laryngoscope; 1998 Jul; 108(7):962-7. PubMed ID: 9665239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
    Coulombeau B; Nusa Naiman A; Ceruse P; Froehlich P
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(5):315-20. PubMed ID: 12741293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
    Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James AL
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005053. PubMed ID: 16235390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent respiratory papillomatosis.
    Venkatesan NN; Pine HS; Underbrink MP
    Otolaryngol Clin North Am; 2012 Jun; 45(3):671-94, viii-ix. PubMed ID: 22588043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
    Schraff S; Derkay CS; Burke B; Lawson L
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion.
    Gallagher TQ; Derkay CS
    Expert Opin Pharmacother; 2009 Mar; 10(4):645-55. PubMed ID: 19284366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent respiratory papillomatosis.
    Shykhon M; Kuo M; Pearman K
    Clin Otolaryngol Allied Sci; 2002 Aug; 27(4):237-43. PubMed ID: 12169123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
    Szeps M; Dahlgren L; Aaltonen LM; Öhd J; Kanter-Lewenshon L; Dahlstrand H; Munck-Wikland E; Grandér D; Dalianis T
    J Gen Virol; 2005 Jun; 86(Pt 6):1695-1702. PubMed ID: 15914847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment].
    Geraĭn V; Chireshkin DG
    Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mitomycin-C for respiratory papillomas: clinical, histologic and biochemical correlation.
    Hamza AH; Nasr MM; Deghady AA
    Saudi Med J; 2005 Nov; 26(11):1737-45. PubMed ID: 16311658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The schedule of intralesional papillomatosis treatment with cidofovir].
    Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
    Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.